Emcure Pharmaceuticals revises price of Poviztra semaglutide injection in India
Weight management drug to be available from Rs 3,999 per month from April 3, 2026
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Mumbai Experience Center reflects Agilent’s continued commitment to India
Bharat Bhardwaj, Vice President, Asia Pacific, Agilent Technologies spoke to Viveka Roychowdhury on why Agilent has been…
Lupin completes acquisition of VISUfarma
The integration of VISUfarma has expanded Lupin’s ophthalmology portfolio to over 60 branded products spanning dry eye, glaucoma,…
Glenmark to manage end-to-end commercialisation and distribution for RYALTRIS in US
RYALTRIS is Glenmark’s first innovative product introduced into the US market
Agilent expands India’s scientific ecosystem with new customer experience centre in Mumbai
Agilent Technologies has announced the opening of its Customer Experience Center (CEC) and office in Mumbai, reinforcing its…
Midst global headwinds, CDSCO cracks down on GLP-1 gold rush
As pharma companies deal with price wars, increasing regulatory heat and a volatile geopolitical situation, navigating this…
Express Pharma April 2026
India's Foremost Pharma & Biotech Magazine ~ Patent Expiries Ahead: Is India Pharma Inc Ready?
Enthral.ai partners with Alembic Pharmaceuticals to deploy LMS platform
Platform to support compliance, training and documentation for over 9,000 learners
Eli Lilly to acquire Centessa Pharmaceuticals under definitive agreement
Acquisition to include orexin receptor portfolio for sleep and neurological conditions
Granules Life Sciences receives VAI classification following US FDA inspection
Granules India announced that its wholly owned subsidiary, Granules Life Sciences (GLS), has concluded a recent US FDA inspection…